We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

101 hedge funds and large institutions have $1.31B invested in Bicycle Therapeutics in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 12

122% more capital invested

Capital invested by funds: $591M → $1.31B (+$721M)

100% more funds holding in top 10

Funds holding in top 10: 4 → 8 (+4)

69% more call options, than puts

Call options by funds: $2.63M | Put options by funds: $1.56M

46% more funds holding

Funds holding: 69 → 101 (+32)

17.65% more ownership

Funds ownership: 55.71% → 73.35% (+18%)

4% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 25

Holders
101
Holders Change
+32
Holders Change %
+46.38%
% of All Funds
1.55%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
45
Increased
26
Reduced
25
Closed
12
Calls
$2.63M
Puts
$1.56M
Net Calls
+$1.07M
Net Calls Change
-$5.01M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.1M
2
RI
RTW Investments
New York
+$48M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.9M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$31.5M
5
Victory Capital Management
Victory Capital Management
Texas
+$22.9M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$33.4M
2
SHI
SV Health Investors
Massachusetts
-$28.6M
3
AVA
Atlas Venture Advisors
Massachusetts
-$12.8M
4
SC
Samlyn Capital
New York
-$8.04M
5
GTC
Ghost Tree Capital
New York
-$4.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$9.13M +$298K +5,399 +4%
Axa
27
Axa
France
$8.84M -$2.95M -53,421 -27%
DWA
28
Dorsey Wright & Associates
California
$7.96M +$162K +2,938 +2%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$5.92M +$2.79M +50,500 +108%
Handelsbanken Fonder
30
Handelsbanken Fonder
Sweden
$4.87M +$4.41M +80,000 New
Renaissance Technologies
31
Renaissance Technologies
New York
$4.45M +$4.04M +73,179 New
PHP
32
Parkman Healthcare Partners
Connecticut
$3.94M -$262K -4,749 -7%
BFM
33
Boothbay Fund Management
New York
$3.86M +$470K +8,510 +15%
Citadel Advisors
34
Citadel Advisors
Florida
$3.54M +$1.81M +32,840 +130%
SCM
35
Sio Capital Management
New York
$3.29M +$2.98M +54,000 New
BG
36
Bellevue Group
Switzerland
$3.27M -$662K -12,000 -18%
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$3.2M +$2.9M +52,575 New
Marshall Wace
38
Marshall Wace
United Kingdom
$3.07M +$2.36M +42,704 +555%
GCM
39
Goldstream Capital Management
Hong Kong
$2.94M +$2.66M +48,257 New
Envestnet Asset Management
40
Envestnet Asset Management
Illinois
$2.51M -$111K -2,004 -5%
LP
41
LMR Partners
United Kingdom
$2.44M +$2.21M +40,000 New
PCM
42
Pentwater Capital Management
Florida
$2.4M +$1.52M +27,500 +229%
Stifel Financial
43
Stifel Financial
Missouri
$2.13M -$162K -2,928 -8%
HCA
44
Harbor Capital Advisors
Illinois
$2.11M +$1.91M +34,600 New
TD Asset Management
45
TD Asset Management
Ontario, Canada
$1.92M +$1.74M +31,586 New
LCM
46
Laurion Capital Management
New York
$1.91M -$206K -3,734 -11%
JF
47
Jump Financial
Illinois
$1.9M +$773K +14,007 +81%
Goldman Sachs
48
Goldman Sachs
New York
$1.26M +$321K +5,824 +39%
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$1.11M +$1.01M +18,260 New
VIA
50
Vident Investment Advisory
Georgia
$1.09M +$989K +17,933 New
1
2
3 4 5

BCYC Hedge Fund Activity: Q4 2021 in Review

101 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q4 2021, worth a combined $1.31B — up 122% from $591M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new BCYC positions and 12 closed out — a net gain of 33 holders — while 26 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $55.1M. The largest seller was Logos Global Management, cutting an estimated $33.4M.

  • 101 institutional investors held Bicycle Therapeutics (BCYC) as of Q4 2021, up from 69 in Q3 2021.
  • Funds reported $1.31B of Bicycle Therapeutics stock for Q4 2021, up 122% quarter-over-quarter.
  • 45 funds opened new Bicycle Therapeutics positions in Q4 2021 and 12 closed out, a net change of +33 holders.
  • The largest Bicycle Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $55.1M added.
  • The largest Bicycle Therapeutics seller in Q4 2021 was Logos Global Management, an estimated $33.4M sold.

Based on aggregated 13F filings for Q4 2021.